Today: 9 June 2026
UniFirst stock jumps after report of renewed Cintas buyout talks
10 February 2026
1 min read

UniFirst stock jumps after report of renewed Cintas buyout talks

New York, Feb 10, 2026, 10:29 EST — Regular session

  • UniFirst surged roughly 16% after reports surfaced that Cintas is in active acquisition discussions with the company.
  • The stock remains far beneath Cintas’ December offer of $275 per share.
  • Traders are on the lookout for a company statement or filing confirming the talks.

Shares of UniFirst Corp shot up 15.6% to $231.00 Tuesday morning, following a report indicating the uniform supplier has resumed talks with larger competitor Cintas over a potential sale.

This is significant: for months, the stock has been shadowed by speculation—now there’s an actual price. UniFirst remains about 16% under Cintas’s $275-a-share bid, so there’s still plenty of daylight for traders looking to capitalize.

That old question is back on the table: will UniFirst’s board actually come to the table now, or are we heading for another round of deadlock? The gap between UniFirst’s share price and the offer makes it clear—plenty of investors doubt the negotiations will actually stick this time.

According to people with knowledge of the situation, UniFirst is back at the table with Cintas, which put forward a renewed $275-per-share offer in December, Bloomberg News reported. While sources say the deal talks are under wraps, there’s still a chance the negotiations could fall apart.

Cintas shares climbed 2.8% in morning trade. That’s a modest gain—typical when the acquirer is the bigger player and investors begin sizing up discipline on price and potential deal risks.

Back in December, Cintas went public with its latest offer: $5.2 billion, translating to $275 a share in cash for UniFirst. That marked its third try, after previous efforts in 2022 and one more shot that fizzled last year. The bid also came with a $350 million reverse termination fee—essentially, a payout to UniFirst if regulators scuttle the deal. CEO Todd Schneider pushed the narrative that “stronger together than we are apart.” Reuters

UniFirst handles everything from workplace uniform rental and laundry to making uniforms and specialty garments, plus first-aid and safety products, its company profile shows.

Plenty could still go wrong here. UniFirst’s dual-class setup gives Class B shares ten votes apiece, piling up voting power and muddying the waters for any deal. Deciding isn’t just about the price, not with this structure.

At this point, the stock’s behaving more like a bet on whether the deal goes through than a sure thing. Investors are ponying up for a shot at UniFirst making a move, though the price is well below that $275 mark.

The next spark? Straightforward and close at hand: traders are on alert for any official word—be it a board update, SEC filing, or on-the-record comment—that either confirms negotiations or hints at a shift in the bid. Eyes are on headlines dropping before the U.S. market closes.

Stock Market Today

  • Dow Jones Rises on Optimism Over U.S.-Iran Deal; Micron and SanDisk Stocks Rebound
    June 9, 2026, 10:02 AM EDT. The Dow Jones Industrial Average climbed Tuesday following President Trump's remarks suggesting a U.S.-Iran agreement could be finalized within "two or three days." This positive geopolitical development boosted market sentiment. Meanwhile, tech stocks Micron Technology and SanDisk gained further momentum, continuing their recent recovery. Investors responded to potential easing of Middle East tensions and improving semiconductor sector outlook. The comments and sector performance provided broad support for the market's advance.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
BAT share price slips again as buyback filing lands and Capital Group trims stake ahead of results
Previous Story

BAT share price slips again as buyback filing lands and Capital Group trims stake ahead of results

Legal & General share price slips as AI disruption worries keep UK insurers on edge
Next Story

Legal & General share price slips as AI disruption worries keep UK insurers on edge

Go toTop